Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FlowAid Medical Technologies is a private medical device company focused on non-invasive technologies to improve blood circulation in the extremities. Its lead commercial product is the FA100 SCCD, a portable four-channel electrical muscle stimulation device designed to increase local blood circulation, help prevent post-surgical venous thrombosis, reduce edema, and retard disuse atrophy. The company positions its technology as an alternative to traditional external compression approaches by using sequential stimulation of calf muscles to promote circulatory enhancement. FlowAid appears to operate as a small commercial-stage medtech business rather than a drug-development biotech company, with FDA 510(k) clearance and CE mark history supporting commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FlowAid Medical Technologies.